Similar results were observed in a study by Ma et al., in which cisplatin-resistant NSCLC exosomal miR-425-3p facilitated autophagic activation and conferred cisplatin resistance in sensitive cells by also targeting the AKT1/mTOR signaling pathway [114]. Here, MTOR is linked to non-small cell lung carcinoma.